Repeated treatment with alpidem, a new anxiolytic, does not induce tolerance or physical dependence.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Neuropharmacology

• Publication date

  1993-09-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/0028-3908(93)90140-XPMID 7901790
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Changes in seizure threshold and aggression during chronic treatment with three anticonvulsants and on drug withdrawal

  2005cited by this paper
• Tolerance to the anti-pentylenetetrazole effects of diazepam in the mouse

  2004cited by this paper
• Structural variety of GABAA receptors and specificity of benzodiazepines pharmacological profiles.

  1992cited by this paper
• Benzodiazepines: use, abuse, and consequences.

  1992cited by this paper
• Bi-directional changes in the levels of messenger RNAs encoding gamma-aminobutyric acidA receptor alpha subunits after flurazepam treatment.

  1992cited by this paper
• GABAA receptor subunit mRNA levels are differentially influenced by chronic FG 7142 and diazepam exposure.

  1992cited by this paper
• Bi-directional changes in the levels of messenger RNAs encoding γ-aminobutyric acidA receptor α subunits after flurazepam treatment

  1992cited by this paper
• Lack of tolerance and physical dependence upon repeated treatment with the novel hypnotic zolpidem.

  1992cited by this paper
• Chronic benzodiazepine administration. X. Concurrent administration of the peripheral-type benzodiazepine ligand PK11195 attenuates chronic effects of lorazepam.

  1992cited by this paper
• 2-Aryl-3-indoleacetamides (FGIN-1): a new class of potent and specific ligands for the mitochondrial DBI receptor (MDR).

  1992cited by this paper
• Ro 19-8022, a nonbenzodiazepine partial agonist at benzodiazepine receptors: neuropharmacological profile of a potential anxiolytic.

  1992cited by this paper
• Decreased GABAA receptor subunit mRNA concentrations following chronic lorazepam administration

  1991cited by this paper
• Influence of recombinant gamma-aminobutyric acid-A receptor subunit composition on the action of allosteric modulators of gamma-aminobutyric acid-gated Cl- currents.

  1991cited by this paper
• gamma-Aminobutyric acid type A receptor point mutation increases the affinity of compounds for the benzodiazepine site.

  1991cited by this paper
• Physical dependence induced in DBA/2J mice by benzodiazepine receptor full agonists, but not by the partial agonist Ro 16-6028.

  1990cited by this paper
• Reduction of reticulata neuronal activity by zolpidem and alpidem, two imidazopyridines with high affinity for type I benzodiazepine receptors.

  1990cited by this paper
• Involvement of the "peripheral" benzodiazepine receptor type (omega 3) in the tolerance to the electroencephalographic effects of benzodiazepines in rats: comparison of diazepam and clonazepam.

  1990cited by this paper
• Differential effects of chronic lorazepam and alprazolam on benzodiazepine binding and GABAA‐receptor function

  1990cited by this paper
• Gamma-aminobutyric acidA receptor alpha 5-subunit creates novel type II benzodiazepine receptor pharmacology.

  1990cited by this paper
• Chronic benzodiazepine administration. VI. A partial agonist produces behavioral effects without tolerance or receptor alterations.

  1990cited by this paper
• Studies with Alpidem in Normal Volunteers and Anxious Patients

  1990cited by this paper
• The history of benzodiazepine dependence: a review of animal studies.

  1990cited by this paper
• Pharmacological and Behavioral Profile of Alpidem as an Anxiolytic

  1990cited by this paper
• Selectivity for Omega-Receptor Subtypes as a Strategy for the Development of Anxiolytic Drugs

  1990cited by this paper
• γ‐Aminobutyric AcidA Receptor α5‐Subunit Creates Novel Type II Benzodiazepine Receptor Pharmacology

  1990cited by this paper
• Regional GABA/benzodiazepine receptor/chloride channel coupling after acute and chronic benzodiazepine treatment.

  1989cited by this paper
• Lack of anticonvulsant tolerance with RU 32698 and Ro 17-1812.

  1989cited by this paper
• Chronic diazepam treatment produces regionally specific changes in GABA-stimulated chloride influx.

  1989cited by this paper
• Relationship of agonist efficacy to changes in GABA sensitivity and anticonvulsant tolerance following chronic benzodiazepine ligand exposure.

  1989cited by this paper
• Responses of substantia nigra pars reticulata neurons to benzodiazepine ligands after acute and prolonged diazepam exposure. I. Modulation of gamma-aminobutyric acid sensitivity.

  1989cited by this paper
• Co-existence of kindling induced by the beta-carboline, FG 7142, and tolerance to diazepam following chronic treatment in mice.

  1988cited by this paper
• Ro 15-1788-induced seizures in rats continually exposed to diazepam for prolonged periods.

  1988cited by this paper
• RO 16-6028, a benzodiazepine receptor partial agonist, does not exhibit anticonvulsant tolerance in mice.

  1988cited by this paper
• Tolerance to the anticonvulsant effect of clorazepate and clonazepam in mice.

  1988cited by this paper
• LIMITATIONS OF THE BENZODIAZEPINE RECEPTOR NOMENCLATURE: A PROPOSAL FOR A PHARMACOLOGICAL CLASSIFICATION AS OMEGA RECEPTOR SUBTYPES

  1988cited by this paper
• Rapid induction of lorazepam dependence and reversal with flumazenil.

  1988cited by this paper
• Chronic benzodiazepine treatment increases the effects of the inverse agonist FG7142.

  1988cited by this paper
• Imidazopyridines as a tool for the characterization of benzodiazepine receptors: a proposal for a pharmacological classification as omega receptor subtypes.

  1988cited by this paper
• Chronic treatment with lorazepam and FG 7142 may change the effects of benzodiazepine receptor agonists, antagonists and inverse agonists by different mechanisms.

  1987cited by this paper
• Lack of tolerance or withdrawal effects in mice after chronic administration of the non-sedating anxiolytic, CGS 9896.

  1987cited by this paper
• Time course for development of anticonvulsant tolerance and GABAergic subsensitivity after chronic diazepam.

  1987cited by this paper
• Tolerance to anti-pentylenetetrazol effects following chronic diazepam.

  1986cited by this paper
• Benzodiazepine dependence in the clinic: reason for anxiety?

  1986cited by this paper
• Tolerance to the anticonvulsant action of benzodiazepines. Relationship to decreased receptor density.

  1985cited by this paper
• Continuous release of diazepam: electrophysiological, biochemical and behavioral consequences.

  1985cited by this paper
• Tolerance to the behavioral actions of benzodiazepines.

  1985cited by this paper
• Chronic benzodiazepine treatment decreases postsynaptic GABA sensitivity

  1984cited by this paper
• Development of tolerance to the anticonvulsant effects of clobazam.

  1983cited by this paper
• Use of the specific benzodiazepine antagonist, Ro 15-1788, in studies of physiological dependence on benzodiazepines

  1982cited by this paper
• gamma-Aminobutyric acid (GABA) receptor stimulation. I. Neuropharmacological profiles of progabide (SL 76002) and SL 75102, with emphasis on their anticonvulsant spectra.

  1982cited by this paper
• A simplified method of evaluating dose-effect experiments.

  1948cited by this paper
• COMPARATIVE ANTICONVULSIVE ACTION OF 3,5,5-TRIMETHYLOXAZOLIDINE-2,4-DIONE (TRIDIONE), DILANTIN AND PHENOBARBITAL

  1944cited by this paper

• Psychopharmacological effects and safety of styryl‐2‐pyrones and dihydrostyryl‐2‐pyrones‐rich fraction from Polygala sabulosa: absence of withdrawal syndrome and tolerance to anxiolytic‐like and anticonvulsant effects

  2018influential citation
• Anxioselective anxiolytics: on a quest for the Holy Grail.

  2012cites this paper
• Lack of tolerance to anxiolysis and withdrawal symptoms in mice repeatedly treated with AC-5216, a selective TSPO ligand.

  2009influential citation
• Plasticity of GABAergic synaptic inhibition in vitro and in vivo : from GABA[A tiefgestellt] receptor endocytosis to the development of sedative tolerance to diazepam

  2005cites this paper
• COX-2 Inhibitors

  2004cites this paper
• Requirement of α5-GABAA Receptors for the Development of Tolerance to the Sedative Action of Diazepam in Mice

  2004cites this paper
• SL651498, a GABAA receptor agonist with subtype-selective efficacy, as a potential treatment for generalized anxiety disorder and muscle spasms.

  2003cites this paper
• SL651498: An Anxioselective Compound with Functional Selectivity for α2- and α3-Containing γ-Aminobutyric AcidA (GABAA) Receptors

  2001cites this paper
• SL651498: an anxioselective compound with functional selectivity for alpha2- and alpha3-containing gamma-aminobutyric acid(A) (GABA(A)) receptors.

  2001cites this paper
• Zaleplon - a review of a novel sedative hypnotic used in the treatment of insomnia

  2000cites this paper
• Agonist efficacy, drug dependence, and medications development: preclinical evaluation of opioid, dopaminergic, and GABAA-ergic ligands

  2000cites this paper
• Subtype-selective benzodiazepine receptor ligands

  2000cites this paper
• Neuroactive flavonoids: new ligands for the Benzodiazepine receptors.

  1998cites this paper
• Pharmacology of mammalian GABA-A receptors

  1997cites this paper
• Overview—Flavonoids: A New Family of Benzodiazepine Receptor Ligands

  1997cites this paper
• Neurotherapeutics

  1996cites this paper
• Sensitization of gamma-aminobutyric acidA receptors to neuroactive steroids in rats during ethanol withdrawal.

  1996cites this paper
• A nonbenzodiazepine partial agonist, S-(+)-DN-2327, has minimal physical dependence-producing liability, but shows cross-dependence on barbital in rats.

  1996cites this paper
• Comparison of the pharmacological profiles of the hypnotic drugs, zaleplon and zolpidem.

  1996cites this paper
• Future directions in anxiolytic pharmacotherapy.

  1995cites this paper
• Assessment of the interaction between a partial agonist and a full agonist of benzodiazepine receptors, based on psychomotor performance and memory, in healthy volunteers

  1995cites this paper
• Recent developments in the behavioral pharmacology of benzodiazepine (omega) receptors: evidence for the functional significance of receptor subtypes.

  1994cites this paper
• Tolerance, cross-tolerance and dependence measured by operant responding in rats treated with triazolam via osmotic pumps

  1994cites this paper